Heart Failure and Sleep-Disordered Breathing: Susceptibility to Reduced Muscle Strength and Preclinical Congestion (SICA-HF Cohort)
Authors:
Open Access
- 23 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 7 (5) , 2063-2070
Abstract
Aims Increased sympathetic activation in patients with heart failure (HF) and sleep‐disordered breathing (SDB) provokes cardiac decompensation and protein degradation and could lead to muscle wasting and muscle weakness. The aim of this study was to investigate the differences in body composition, muscle function, and the susceptibility of preclinical congestion among patients with HF and SDB compared with those without SDB. Methods and results We studied 111 outpatients with stable HF who were enrolled into the Studies Investigating Co‐morbidities Aggravating Heart Failure. Echocardiography, short physical performance battery (SPPB), cardiopulmonary exercise testing, dual‐energy X‐ray absorptiometry, bioelectrical impedance analysis (BIA), tests of muscle strength, and polygraphy were performed. SDB was defined as apnoea/hypopnoea index (AHI) >5 per hour of sleep. Central sleep apnoea (CSA) and obstructive sleep apnoea (OSA) were defined as AHI >50% of central or obstructive origin, respectively. A total of 74 patients (66.7%) had any form of SDB [CSA (24 patients, 32.4%), OSA (47 patients, 63.5%)]. Patients with SDB showed increased muscle weakness (chair stand), reduced muscle strength, and lower values of SPPB score (P < 0.05). Patients with SDB did not show overt clinical signs of cardiac decompensation compared with those without SDB (P > 0.05) but had increased amounts of water (total body water, intracellular, and extracellular) measured using BIA (P < 0.05). Increased amounts of total body water were associated with the severity of SDB and inversely with muscle strength and exercise capacity measured by anaerobic threshold (P < 0.05). Altogether, 17 patients had muscle wasting. Of these, 11 (65%) patients had SDB (statistically not significant). Conclusions SDB is highly prevalent in patients with HF. Patients with SDB have lower muscle strength and tend to be more susceptible to preclinical congestion.Keywords
Funding Information
- X_OA_3121_ProjektDEAL (X_OA_3121_ProjektDEAL)
- X_OA_3121_ProjektDEAL
This publication has 31 references indexed in Scilit:
- Sleep-Disordered Breathing in Heart Failure: Identifying and Treating an Important but Often Unrecognized Comorbidity in Heart Failure PatientsJournal of Cardiac Failure, 2013
- The use of dual-energy X-ray absorptiometry in the evaluation of obesity in women with obstructive sleep apnea–hypopnea syndromeEuropean Archives of Oto-Rhino-Laryngology, 2012
- Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF)Journal of Cachexia, Sarcopenia and Muscle, 2010
- Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failureEuropean Heart Journal, 2010
- Executive Summary: Heart Disease and Stroke Statistics—2010 UpdateCirculation, 2010
- Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failureArchives of Cardiovascular Diseases, 2009
- Continuous Positive Airway Pressure for Obstructive Sleep ApneaNew England Journal of Medicine, 2007
- Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep ApneaHypertension, 2005
- A Mechanism of Central Sleep Apnea in Patients with Heart FailureNew England Journal of Medicine, 1999
- Adverse consequences of high sympathetic nervous activity in the failing human heartJACC, 1995